A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia resp

Author:  ["Pavan Reddy","Yoshinobu Maeda","Chen Liu","Oleg I Krijanovski","Robert Korngold","James L M Ferrara"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Graft-versus-leukemia (GVL) response after allogeneic bone marrow transplantation (BMT) represents one of the most potent forms of immunotherapy against malignant diseases1. Antigen-presenting cells (APCs) are crucial for the induction of graft-versus-host disease (GVHD)2,3,4,5,6, the most serious complication of allogeneic BMT, but their role in GVL responses is unclear. Using a series of clinically relevant mouse GVL tumor models, we found that APCs and alloantigen expression on tumors are crucial for GVL. Moreover, APCs of host origin predominated in GVL responses although donor APCs contributed as the acuity of tumor burden decreased.

Cite this article

Reddy, P., Maeda, Y., Liu, C. et al. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 11, 1244–1249 (2005). https://doi.org/10.1038/nm1309

View full text

>> Full Text:   A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia resp

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells